Survey of Predictors of Human Papillomavirus (HPV) Vaccination Among Parents of Rural Adolescent Girls in Mysore, India

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Public Health Research Institute, India.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Public Health Research Institute, India
ClinicalTrials.gov Identifier:
NCT01307774
First received: March 2, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted
  Purpose

To conduct a quantitative survey to measure knowledge about Human papillomavirus (HPV) and cervical cancer, and HPV vaccine acceptability among parents of rural adolescent girls in Mysore District, India.

Hypothesis: General knowledge and attitudes about the severity and treat ability of cancer will predict acceptability of HPV vaccination among parents of rural adolescent girls in Mysore, India.


Condition
Human Papillomavirus
Cervical Cancer

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Survey of Predictors of HPV Vaccination Among Parents of Rural Adolescent Girls in Mysore, India

Resource links provided by NLM:


Further study details as provided by Public Health Research Institute, India:

Estimated Enrollment: 800
Study Start Date: June 2011
  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The study will survey attitudes of parents of adolescent girls attending 10 schools in rural Mysore Taluk in Mysore District.

Criteria

Inclusion Criteria:

  • over 18 years of age
  • parent of an adolescent girl (10 -15 years of age)
  • able to speak English or Kannada
  • willing to undergo informed consent process

Exclusion Criteria:

  • Does not have the capacity to undergo informed consent process
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01307774

Contacts
Contact: Vijaya Srinivas, MD +91 821 425 9555 drvijaya09@gmail.com
Contact: Purnima Madhivanan, MBBS, PhD +91 821 425 9555 pmadhivanan2@gmail.com

Locations
India
Public Health Research Institute of India Not yet recruiting
Mysore, Karnataka, India, 570020
Contact: Vijaya Srinivas, MD    +91 821 425 9555    drvijaya09@gmail.com   
Contact: Purnima Madhivanan, MBBS, PhD    +91 821 425 9555    pmadhivanan2@gmail.com   
Sub-Investigator: Vijaya Srinivas, MD         
Sponsors and Collaborators
Public Health Research Institute, India
Investigators
Principal Investigator: Purnima Madhivanan, MBBS, PhD Public Health Research Institute of India
  More Information

Publications:
Responsible Party: Purnima Madhivanan, Public Health Research Institute, India
ClinicalTrials.gov Identifier: NCT01307774     History of Changes
Other Study ID Numbers: IISP38250
Study First Received: March 2, 2011
Last Updated: March 2, 2011
Health Authority: India: Institutional Review Board

Keywords provided by Public Health Research Institute, India:
parental acceptability of HPV vaccine

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on July 29, 2014